Vedanta Biosciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor conferences: Wells Fargo Virtual Private Biotech Symposium Date: Monday, May 6, 2024 Virtual 1x1 meetings only The Citizens JMP Life Sciences Conference Dates: May 13-14, 2024 Presentation: Tuesday, May 14 at 12:30 p.m. ET L